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Expression of EphB2 in PKCgamma
and Calretinin Interneuron 
Subpopulations After Spinal Cord 
Injury.
David Jaffe, Nicolette Heinsinger, Angelo Lepore*
Introduction
• Neuropathic Pain
– A majority of patients with spinal 
cord injury (SCI)
• Debilitating and difficult to 
treat
– “Freedom from pain is often not 
realistic”
– antidepressant, antiepileptic, 
opioids
Introduction
• Dorsal horn sensitization




– Linked to neuropathic pain





–Does EphB2 mRNA increase in PKCγ or 
calretinin expressing dorsal horn neurons in 
mice with SCI compared to laminectomy-only 
controls?
• Hypothesis
–Mice with SCI will have increased EphB2 
mRNA in PKCγ or calretinin expressing dorsal 
horn neurons compared to their 
laminectomy-only controls.
Approach & Results
• Animal Study: mice
• Design
– C5/C6 spinal cord 
contusion injury vs. 
Laminectomy-only 
controls
– mRNA labelled in sliced 
cords using RNAscope




– Semi-automated system 
that counted mRNA 
transcripts per cell after user 
outlining
• Rationale for Approach
– Previously uninvestigated
– Immunohistochemistry 
consolidates in the dendrites
Approach & Results
• Analysis
– 2 independent means T-test 
– Each interneuron population was quantified and 
compared separately (PKCγ and Calretinin)
Approach & Results
• PKCgamma expressing 
interneurons
– 5.38 vs. 6.15 Transcripts
– P-value = 0.23
ns
Approach & Results
• Calretinin expressing 
interneurons 
– 4.83 vs. 5.15 Transcripts




– No significant difference between EphB2 mRNA levels 
in subpopulations of dorsal horn neurons in SCI vs. 
laminectomy-only mice
– Targeting EphB2 in these interneuron populations may 
not be therapeutic
• Context
– While previous studies have demonstrated an increase 
in EphB2 expression after SCI in spinal cord neurons, 
these two subpopulations are likely not responsible
Future Directions
• Next steps
– Look at actual protein expression instead of 
mRNA
– Look for EphB2 expression after spinal cord 
injury in different populations of dorsal horn 
interneurons
– Look at different members of the Eph/Ephrin 
family of proteins
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